首页 | 本学科首页   官方微博 | 高级检索  
检索        

急性心肌梗死尿激酶与重组链激酶急诊溶栓治疗的临床分析
引用本文:张宁,苏文军,高雯,张庆华,金洋,王建,杨志栋.急性心肌梗死尿激酶与重组链激酶急诊溶栓治疗的临床分析[J].疾病监测与控制杂志,2013,7(3):137-138.
作者姓名:张宁  苏文军  高雯  张庆华  金洋  王建  杨志栋
作者单位:巴彦淖尔市医院急诊科,内蒙古 巴彦淖尔,015000
摘    要:目的 比较尿激酶与重组链激酶溶栓再通率.方法 收集2006年1月~2012年12月来我院急诊科就诊符合静脉溶栓要求的AMI病人120例,入院后立即给予静脉溶栓治疗.结果 重组链激酶溶栓开通率高于尿激酶,差异有统计学意义.结论 重组链激酶比尿激酶更值得在STEA-MI溶栓治疗中临床推广使用.

关 键 词:溶栓治疗  急性心肌梗死  急诊

CHnical analysis of urokinase and recombinant streptokinase emergency thrombolytic therapy in acutemyocardial infarction
Authors:ZHANG Ning  SU Wen-jun  GAO Wen  ZHAHG Qing-hna  JIN Yang  WANG Jian  yang Zhi-dong
Institution:. (Bayannao Hospital, Bayannao 010050, China)
Abstract:Objective Compare urokinase and recombinant streptokinase thrombolytic recanalization rate. Methods Collection in January 2006 December 2012 to intravenous Thrombolysis in our emergency department visits in accordance with requirements of 120 patients with AMI, thrombolytic treatment given immediately after admission. Results Recombinant streptokinase in thrombolytic opened than urokinase, differences are statistically significant. Conclusion Recombinant streptokinase is more worthy than urokinase in the stea-mi thrombolytic therapy in clinical use.
Keywords:Thrombolytic therapy: Acute myocardial infarction: Emergency
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号